Feature piece on Sofinnova Partners' decade-long backing of HighLife ahead of its recent $90M+ raise.
HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to patients
HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to patients.